Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPP9 antisense RNA 1 (DPP9-AS1) is a long non-coding RNA transcript located antisense to the DPP9 gene. Long non-coding RNAs such as DPP9-AS1 typically function in gene regulation at the transcriptional or post-transcriptional level, but there is currently limited information available about the biological role, expression pattern, disease relevance, or potential as a therapeutic target for DPP9-AS1 specifically. No reports describe drugs or biomarkers associated with DPP9-AS1, and there is no evidence it is classified as a therapeutic target such as an enzyme, receptor, transporter, or other protein class. Some confusion may arise because its name is similar to the protein-coding DPP9 gene, which is a member of the dipeptidyl peptidase family with roles in immune regulation and cancer biology[1][2][3][4][5]; however, DPP9-AS1 is a distinct RNA molecule and not itself an established therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPP9 antisense RNA 1 (DPP9-AS1).